Behind the paper
Share the real story behind your paper, from conception to publication, the highs and the lows.
Operationalizing genomic epidemiology during the Nord Kivu Ebola outbreak, Democratic Republic of Congo
In July 2018, the National Biomedical Research Institute (INRB), in the Democratic Republic of Congo (DRC), set up a pathogen genomics laboratory which allowed us to confirm epidemics of Ebola Virus Disease in the country and to establish epidemiological links between confirmed cases (1-3).
A biomarker study informs the clinical development of novel strategies: the unanticipated impact of the ANTICIPATE study
“Our compound neutralizes antibiotics in the large intestines and prevents gut microbiota disruption. Could we collaborate on its clinical development?” That was the question that brought the French biotech company Da Volterra into COMBACTE.
